Media Release – Kiwis with MS ‘light years’ behind Aussie patients in treatment access and quality of life – study.
Media Release: 14 September 2021 (For Immediate Release) A new trans-Tasman study has highlighted alarming health inequities between New Zealand patients living with multiple sclerosis (MS) and their Australian counterparts — adding fuel to the ongoing fight for Pharmac to “do the right thing” and increase access to drug treatments here. “We’ve known for many […]
McDonald 2017 finally receives PTAC recognition
Still unfunded, but finally acknowledged, McDonald 2017 criteria for diagnosing Multiple Sclerosis (MS) is one step closer to being used in NZ for accessing treatment. The February 2021 minutes of PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC) were released this month, recommending a medium priority to funding the access criteria to include McDonald 2017 MS. “The Committee […]